Zoll Ther Ox
Medical Devices, Cartwright Rd Ste 100, San Jose, , 92614, California, 17500, United States, 11-50 Employees
Phone Number: +13*********
Who is ZOLL THEROX
TherOx is a part of ZOLL Medical Corporation. Based in San Jose, California, TherOx is focused on improving the treatment of heart attacks (acute myocardial infarction, or AMI). The compa...
Read More
-
Headquarters: 17500 Cartwright Rd Ste 100, San Jose, California, 92614, United States
-
Date Founded: 1995
-
Employees: 11-50
-
Revenue: $10 Million to $25 Million
-
Active Tech Stack: See technologies
Industry: Medical Devices
SIC Code: 3841
|
NAICS Code: 339112 |
Show More
Does something look wrong? Fix it. | View contact records from ZOLL THEROX
ZOLL TherOx Org Chart and Mapping
Email
Phone
Similar Companies to ZOLL TherOx
ZOLL Medical Corporation
-
1001-5000
-
$ 1 Billion and Over
Sign in to CIENCE GO Data to uncover contact details
Free credits every month
Frequently Asked Questions Regarding ZOLL TherOx
Answer: ZOLL TherOx's headquarters are located at Cartwright Rd Ste 100, San Jose, , 92614, California, 17500, United States
Answer: ZOLL TherOx's phone number is +13*********
Answer: ZOLL TherOx's official website is https://therox.com
Answer: ZOLL TherOx's revenue is $10 Million to $25 Million
Answer: ZOLL TherOx's SIC: 3841
Answer: ZOLL TherOx's NAICS: 339112
Answer: ZOLL TherOx has 11-50 employees
Answer: ZOLL TherOx is in Medical Devices
Answer: ZOLL TherOx top competitors include: ZOLL Medical Corporation
Answer: ZOLL TherOx contact info: Phone number: +13********* Website: https://therox.com
Answer: TherOx is a part of ZOLL Medical Corporation. Based in San Jose, California, TherOx is focused on improving the treatment of heart attacks (acute myocardial infarction, or AMI). The company is commercializing SuperSaturated Oxygen (SSO2) Therapy for the sizeable AMI patient population to save hearts, improving and ultimately saving lives. SSO2 Therapy is based on the known benefits of hyperbaric oxygen treatment in improving the bodys ability to heal. SSO2 Therapy infuses superoxygenated blood to improve microvascular flow after successful percutaneous coronary intervention (PCI) and has been shown to save heart muscle by reducing infarct size. Immediately after the coronary artery has been opened by PCI, SSO2 Therapy delivers a one-time, 60-minute infusion of the patients superoxygenated blood to the targeted ischemic area of the heart through a small catheter. The superoxygenated blood helps reduce capillary swelling to restore blood flow to surrounding tissue and decrease infarct size. SSO2 Therapy is aligned with current guidelines for interventional cardiology procedures. SSO2 Therapy is indicated for the preparation and delivery of supersaturated oxygen to targeted ischemic regions perfused by the patients left anterior descending coronary artery immediately following revascularization by means of percutaneous coronary intervention (PCI) with stenting that has been completed within six hours after the onset of anterior acute myocardial infarction (AMI) symptoms caused by a left anterior descending artery infarct lesion.
Answer:
Premium Sales Data for Prospecting
-
Sales data across over 200M records
-
Up-to-date records (less decayed data)
-
Accurate Email Lists (real-world tested)
-
Powerful search engine and intuitive interface
Get Full Access
Sign in to CIENCE GO Data to uncover contact details
Free credits every month